- ASCO 2019 meeting review
-
Diver E, Dorigo O, Berek J
- KMID: 2457166
- J Gynecol Oncol.
- 2019 Sep;30(5):e107.
- doi: 10.3802/jgo.2019.30.e107
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment
-
Kwon JS
- KMID: 2457160
- J Gynecol Oncol.
- 2019 Sep;30(5):e92.
- doi: 10.3802/jgo.2019.30.e92
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey
-
Kim M, Kim YB, Kim JW
- KMID: 2457167
- J Gynecol Oncol.
- 2019 Sep;30(5):e108.
- doi: 10.3802/jgo.2019.30.e108
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- How to use immune checkpoint inhibitor in ovarian cancer?
-
Park J, Lee JY, Kim S
- KMID: 2457164
- J Gynecol Oncol.
- 2019 Sep;30(5):e105.
- doi: 10.3802/jgo.2019.30.e105
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter to editor in response to: prior uterine myoma and risk of ovarian cancer: a population-based case-control study
-
Oxley SG, Sirkeci F, Odejinmi F
- KMID: 2457165
- J Gynecol Oncol.
- 2019 Sep;30(5):e106.
- doi: 10.3802/jgo.2019.30.e106
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement
-
Kim M, Kong TW, Kim S, Kim SC, Kim YB, Kim JW, Park JY, Suh DH, Shim SH, Lee KH, Lee SJ, Lee JK, Lim MC
- KMID: 2457163
- J Gynecol Oncol.
- 2019 Sep;30(5):e104.
- doi: 10.3802/jgo.2019.30.e104
On the basis of emerging data and the current understanding of minimally invasive surgery (MIS) for radical hysterectomy (RH) in women with cervical cancer, the Korean Society of Gynecologic Oncology,... -
- CITED
-
- Close
- SHARE
-
- Close
- Aromatase inhibition in ovarian cancer: repeated signals of efficacy but tools for patient selection remain elusive
-
Gourley C
- KMID: 2457161
- J Gynecol Oncol.
- 2019 Sep;30(5):e98.
- doi: 10.3802/jgo.2019.30.e98
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer
-
Tozzi R, Casarin J, Baysal A, Valenti G, Kilic Y, Majd HS, Morotti M
- KMID: 2457162
- J Gynecol Oncol.
- 2019 Sep;30(5):e101.
- doi: 10.3802/jgo.2019.30.e101
The original article by Tozzi et al. entitled, “Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps
-
Heinemann , Masquin I, Blache G, Sabiani L, Jauffret C, Houvenaeghel G, Lambaudie
- KMID: 2457152
- J Gynecol Oncol.
- 2019 Sep;30(5):e74.
- doi: 10.3802/jgo.2019.30.e74
OBJECTIVE: Para-aortic lymphadenectomy was the cornerstone of gynecologic oncology surgery. In endometrial cancer, the quality of para-aortic lymphadenectomy had direct impact on survival of patient. The launch of robot assisted... -
- CITED
-
- Close
- SHARE
-
- Close
- Response to comment on: prior uterine myoma and risk of ovarian cancer: a population-based case-control study
-
Huang CC, Lin CH
- KMID: 2457168
- J Gynecol Oncol.
- 2019 Sep;30(5):e109.
- doi: 10.3802/jgo.2019.30.e109
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy of modified Swede Colposcopic Index in prediction of high-grade lesion and cancer of cervix
-
Rodpenpear N, Pataradool K
- KMID: 2457156
- J Gynecol Oncol.
- 2019 Sep;30(5):e78.
- doi: 10.3802/jgo.2019.30.e78
OBJECTIVE: To evaluate the efficacy of modified Swede Colposcopic Index (MSCI) to predict high-grade lesion and cancer of cervix (CIN2+, cervical intraepithelial neoplasia grade 2 or worse) in women with... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic value of post-treatment ¹â¸F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis
-
Kim YJ, Han S, Kim YS, Nam JH
- KMID: 2457148
- J Gynecol Oncol.
- 2019 Sep;30(5):e66.
- doi: 10.3802/jgo.2019.30.e66
OBJECTIVES: To perform a systematic review and meta-analysis of the prognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography (¹â¸F-FDG PET) in uterine cervical cancer patients treated with radiotherapy (RT) with... -
- CITED
-
- Close
- SHARE
-
- Close
- PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression
-
Kok PS, Beale P, O'Connell , Grant P, Bonaventura T, Scurry J, Antill Y, Goh J, Sjoquist K, DeFazio A, Mapagu C, Amant F, Friedlander M, on behalf of the PARAGON Investigators
- KMID: 2457159
- J Gynecol Oncol.
- 2019 Sep;30(5):e86.
- doi: 10.3802/jgo.2019.30.e86
OBJECTIVE: A subset of patients with recurrent ovarian cancer (ROC) may benefit from antiestrogen therapy with higher response rates reported in tumors that are strongly estrogen receptor (ER)-positive (ER+). PARAGON... -
- CITED
-
- Close
- SHARE
-
- Close
- Involved-field radiation therapy for selected cases of recurrent ovarian cancer
-
Kim N, Chang JS, Kim SW, Kim GM, Lee JY, Kim YB
- KMID: 2457149
- J Gynecol Oncol.
- 2019 Sep;30(5):e67.
- doi: 10.3802/jgo.2019.30.e67
OBJECTIVES: In our institutional experience, involved-field radiation therapy (IFRT) yields favorable outcomes in patients with recurrent epithelial ovarian cancer (EOC). This retrospective study aimed to investigate the clinical benefits of... -
- CITED
-
- Close
- SHARE
-
- Close
- Pseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cells
-
Guan D, Li C, Lv X, Yang Y
- KMID: 2457155
- J Gynecol Oncol.
- 2019 Sep;30(5):e77.
- doi: 10.3802/jgo.2019.30.e77
OBJECTIVES: Pseudolaric acid B (PAB) has been shown to inhibit the growth of various tumor cells, but the molecular details of its function are still unknown. This study investigated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study
-
Ørtoft G, Lausten-Thomsen L, Høgdall C, Hansen ES, Dueholm M
- KMID: 2457158
- J Gynecol Oncol.
- 2019 Sep;30(5):e84.
- doi: 10.3802/jgo.2019.30.e84
OBJECTIVE: To evaluate the effect of lymph-vascular space invasion (LVSI) on location of recurrences in Danish patients with endometrial cancer. METHODS: This national cohort study (2005–2012) included 4,380 radically operated patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study
-
Reijnen C, Visser NC, Kasius JC, Boll D, Geomini PM, Ngo H, Van Hamont D, Pijlman BM, Vos MC, Bulten J, Snijders M, Massuger L, Pijnenborg JM
- KMID: 2457150
- J Gynecol Oncol.
- 2019 Sep;30(5):e70.
- doi: 10.3802/jgo.2019.30.e70
OBJECTIVES: The global obesity epidemic has great impact on the prevalence of low-grade endometrial carcinoma. The preoperative tumor serum marker cancer antigen 125 (CA-125) might contribute to improved identification of... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling
-
Shin HY, Lee B, Hwang SH, Lee DO, Sung NY, Park JY, Jun JK
- KMID: 2457154
- J Gynecol Oncol.
- 2019 Sep;30(5):e76.
- doi: 10.3802/jgo.2019.30.e76
OBJECTIVE: Human papillomavirus testing by self-sampling and urine sampling might be alternatives to Papanicolaou test (Pap test) for cervical cancer screening (CCS), and may increase compliance and adherence thereto. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Overexpression of HER2/HER3 and clinical feature of ovarian cancer
-
Chung YW, Kim S, Hong JH, Lee JK, Lee NW, Lee YS, Song JY
- KMID: 2457153
- J Gynecol Oncol.
- 2019 Sep;30(5):e75.
- doi: 10.3802/jgo.2019.30.e75
OBJECTIVES: Human epidermal growth factor receptor-2 (HER2) and 3 (HER3) belong to the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases. In this study, we assessed HER2/HER3... -
- CITED
-
- Close
- SHARE
-
- Close
- Prior uterine myoma and risk of ovarian cancer: a population-based case-control study
-
Tseng JJ, Huang CC, Chiang HY, Chen YH, Lin CH
- KMID: 2457151
- J Gynecol Oncol.
- 2019 Sep;30(5):e72.
- doi: 10.3802/jgo.2019.30.e72
OBJECTIVE: Uterine myoma which results in the magnitude of ovarian cancer remains uncertain. This study aimed to assess the association between women with previous uterine myoma and the risk of... -
- CITED
-
- Close
- SHARE
-
- Close
